Associated risk factors and prevalence of metabolic syndrome in old people
Keywords:
Risk factors, metabolic syndrome X/epidemiology.Abstract
Introduction: the set of risk factors which may lead to ischemic heart failure, diabetes and diseases related to overweight is known as metabolic syndrome.Objective: to determine the presence of risk factors related to metabolic syndrome and its prevalence in old people.
Material and methods: an observational, descriptive and cross sectional study was carried out in subjects from 60 years old or older attending to two doctors’ offices at "Luis Augusto Turcios Lima" university polyclinic in Pinar del Río.
Results: hypertension and diabetes mellitus developed in the 60% of old people included in the investigation and coexisting in 19.2% of them. Hypertension and ischemic heart disease showed no significant differences in both sexes. Diabetes mellitus prevailed in female sex. Obesity, diabetes and hypertension did not have any association. Prevalence of metabolic syndrome was 78.9% in female sex, while in males 52.3%, significantly higher among female population, which increased with age. The comparison in each group of ages, according to sex, was significant for the group of 60-64 years old, female population showed a greater prevalence concerning metabolic syndrome.
Conclusions: a high figure of hypertensive patients with cardiovascular disease and diabetes was detected. Considering each metabolic disorders, as it is usually associated with metabolic syndrome, it is necessary learning about their correlation for not treating them separately. Its prevalence increases with age.
Downloads
References
1. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older. Diabetes 2003; 52: 1210-14.
2. Muñoz Batista Mayumi de Jesús, Peña Borrego Maricel, Hernández Gárciga Francisco Felipe, Pérez Lemus Juan Francisco, Soler Tejera Iván, Just Matos Carmen Cecilia. Síndrome metabólico en pacientes diabéticos tipo 2 pertenecientes al área de salud Guanabo. Rev Cubana Med Gen Integr [revista en la Internet]. 2010 Jun [citado 2014 May 16] ; 26(2): . Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252010000200008&lng=es
3. Alberti K G, Eckel R H, Grundy S M, Zimmet PZ, Cleeman J I, Donato K A, FruchartJ C, James W P, Loria C M, Smith S C, Jr. Harmonizing the metabolic syndrome:a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120(16):1640-1645.
4. Rodríguez Cabrera Aida, Álvarez Vázquez Luisa, Castañeda Abascal Ileana. La pirámide de población: Precisiones para su utilización. Rev Cubana Salud Pública [revista en la Internet]. 2007 Dic [citado 2013 Sep 16] ; 33(4): . Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662007000400008&lng=es.
5. Mozaffarian D., Kamineni A., Prineas R. y cols.Metabolic Syndrome and Mortality in Older Adults. Arch Intern Med. 2008; 168; 969-978.
6. Tian N, Moore R S, Braddy S, Rose R A, Gu J W, Hughson MD, Manning R D Jr. Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 2007; 293(6):H3388-3395.
7. Alberti KG, Zimmet P.The metabolic syndrome a new worl wide definition from the international diabetes federation consensus. Lancet.2005; 366:1059-62.
8. Deurenberg P, Yap M . Body mass index and percent body fat. A meta analysis among different ethnic group. Int J Obes. 1998; 22:1164-1171.
9. Siest G, Henny J, Schiele F. Interpétation des examens de laboratoire. Kit diagnóstico para determinación enzimática de la glucosa del laboratorio BioMérieux, Francia. Karger ed, 1981; 206-223.
10. Díaz Díaz O, Orlando González N. Manual para el diagnóstico y tratamiento del paciente diabético a nivel primario de salud. La Habana: OPS/OMS; 2011.
11. Jeffrey SF, Maratos-Flier E. Enfermedades del aparato cardiovascular. Enfermedades vasculares. Patogenia de la ateroesclerosis. En: Harrisons Principios de Medicina Interna. 16 Edición; 2011. Cap. 224.
12. Masson W, Siniawski D, Krauss J, Cagide A. Clinical Applicability of the Framingham 30-Year Risk Score. Usefulness in Cardiovascular Risk Stratificationand the Diagnosis of Carotid Atherosclerotic Plaque. Rev Esp Cardiol 2011[citado junio 2012]; 64(4):305-311.Disponible en: http://www.sciencedirect.com/science/article/pii/S1885585711001332
13. Reaven GM. Relationships among insulin resistan-ce, type 2 diabetes, essential hypertension, and cardio-vascular disease: similarities and differences. J Clin Hypertens (Greenwich). 2011; 13 (4):238-43.
14. Rueda Alfaro S, et al. Síndrome metabólico y enfermedad cardiovascular en ancianos: resultados del Estudio de Envejecimiento de Mataró Med Clin (Barc). 2008;130: 327-31.[Acceso 22-05-12]
15. Jesús D. Hernández JD, Alfieri AB, Hoffmann IS, Ramírez A. Factores de riesgo del síndrome metabólico asociados al incremento de la natriuresis Revista Latinoamericana de Hipertensión. 2012;7(3)
16. Park J, Mendoza J A, O'Neil C E., Hilmers D C, Liu Y, Nicklas T A. A comparison of the prevalence of the metabolic syndrome in the United States (US) and Korea in young adults aged 20 to 39 years J Clin Nutr. 2008; 17(3):471-482.

Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/